|

Trastuzumab Injection Clinical Trials

2 actively recruiting trials

▼ -1 trial since July 2026

Pipeline

Phase 2: 1Phase 2/3: 1

Top Sponsors

  • UNICANCER1
  • SUNHO（China）BioPharmaceutical CO., Ltd.1

Indications

  • Cancer2
  • Leptomeningeal Disease1
  • HER2-positive Metastatic Breast Cancer1
  • Stomach Neoplasms1
  • Solid Tumor1

Other2 trials

Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Phase 2
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.